Skip to main content

Table 2 Hemodynamic variables

From: Effects of terlipressin infusion during hepatobiliary surgery on systemic and splanchnic haemodynamics, renal function and blood loss: a double-blind, randomized clinical trial

Variables

Group T N = 25

Group C N = 25

P value

HR (beat/m.)

Baseline

77.3 ± 7.9

80.1 ± 7.7

0.22

Intraoperative

79.6 ± 14.4

84.5 ± 14.5

0.24

Postoperative

85.2 ± 11.3*

90.8 ± 12*

0.09

MAP (mm HG)

Baseline

85.8 ± 8.7

89.4 ± 12.8

0.25

Intraoperative

88.7 ± 7.2

83.9 ± 6.98

0.02¥

Postoperative

80.2 ± 12.3

86.1 ± 9.9

0.07

CVP (mm Hg)

Baseline

14.0 (8–20)

14.0 (8–22)

0.34

Intraoperative

12.4 (8.3–19.2)

12.6 (7.1–21.4)

0.84

Postoperative

9.0 (2–12)”

8.0 (5–21)”

0.60

CI (L/min/m2)

Baseline

3.6 ± 0.9

3.4 ± 1.1

0.43

Intraoperative

3.1 ± 0.3*

3.3 ± 0.6

0.15

SVV %

Baseline

7.4 ± 3.90

9.2 ± 2.98

0.08

Intraoperative

10.6 ± 2.17*

11.0 ± 2.14*

0.50

SVR (dyne.s/cm5)

Baseline

1030.2 ± 318.1

1021.8 ± 285.2

0.92

Intraoperative

1144.9 ± 221.0*

1007.2 ± 232.4

0.04¥

Need for inotropic support, no. of patients

1(4%)

3(12%)

0.30

Inotropic score

5 (5–5)

10(5–10)

0.32

  1. Data are presented as mean ± SD or median (range). HR heart rate; MAP mean arterial pressure; CI cardiac index; SVV stroke volume variation; SVR systemic vascular resistance. P-value <0.05 was considered statistically significant. (*) significant difference in comparison to the baseline value within the same group. (¥) significant difference between the two groups. The inotropic score is calculated as follows: One point was assigned for each mcg/kg/min of dobutamine, and 1 point was assigned for each 10 ng/kg/min of norepinephrine)